Swiss HLG, PLCF & Italy HLG invites you to join us for this timely webinar on the 7th November from 14:30 -16:00 CET.
STRATEGIC COMMERCIALIZATION OPTIONS IN EUROPE FOR MID SIZED HEALTHCARE COMPANIES
Ronald Van Zitteren, Principal at AIM will discuss the challenges faced by New Market Entrants in launching their products in Europe and Francois-Xavier CAPELO, VP International, Bioprojet will talk about Bioprojet’s orphan drug launch in Europe.
These two sessions will be followed by a live Q&A moderated by Bruno Delie, General Manager, Luye Pharma EU.
2023 © Swiss HLG | by evago.fr
Cookies settings